Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring syst… Read more
Market Cap & Net Worth: Iradimed Co (IRMD)
Iradimed Co (NASDAQ:IRMD) has a market capitalization of $1.31 Billion ($1.31 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8004 globally and #4128 in its home market, demonstrating a 2.62% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Iradimed Co's stock price $102.80 by its total outstanding shares 12721156 (12.72 Million).
Iradimed Co Market Cap History: 2015 to 2026
Iradimed Co's market capitalization history from 2015 to 2026. Data shows growth from $331.13 Million to $1.31 Billion (14.46% CAGR).
Index Memberships
Iradimed Co is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.04% | #221 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #877 of 3165 |
Weight: Iradimed Co's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Iradimed Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Iradimed Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.77x
Iradimed Co's market cap is 14.77 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
55.05x
Iradimed Co's market cap is 55.05 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $131.13 Million | $32.50 Million | $7.21 Million | 4.04x | 18.18x |
| 2017 | $178.97 Million | $23.08 Million | $499.76K | 7.75x | 358.11x |
| 2018 | $288.95 Million | $30.44 Million | $6.30 Million | 9.49x | 45.84x |
| 2019 | $276.20 Million | $38.52 Million | $9.63 Million | 7.17x | 28.68x |
| 2020 | $269.35 Million | $31.72 Million | $1.37 Million | 8.49x | 196.75x |
| 2021 | $545.90 Million | $41.81 Million | $9.33 Million | 13.06x | 58.54x |
| 2022 | $341.02 Million | $53.30 Million | $12.83 Million | 6.40x | 26.59x |
| 2023 | $598.06 Million | $65.56 Million | $17.19 Million | 9.12x | 34.79x |
| 2024 | $699.66 Million | $73.24 Million | $19.23 Million | 9.55x | 36.38x |
| 2025 | $1.24 Billion | $83.81 Million | $22.48 Million | 14.77x | 55.05x |
Competitor Companies of IRMD by Market Capitalization
Companies near Iradimed Co in the global market cap rankings as of March 18, 2026.
Key companies related to Iradimed Co by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Iradimed Co Historical Marketcap From 2015 to 2026
Between 2015 and today, Iradimed Co's market cap moved from $331.13 Million to $ 1.31 Billion, with a yearly change of 14.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.31 Billion | +5.67% |
| 2025 | $1.24 Billion | +76.87% |
| 2024 | $699.66 Million | +16.99% |
| 2023 | $598.06 Million | +75.37% |
| 2022 | $341.02 Million | -37.53% |
| 2021 | $545.90 Million | +102.68% |
| 2020 | $269.35 Million | -2.48% |
| 2019 | $276.20 Million | -4.42% |
| 2018 | $288.95 Million | +61.45% |
| 2017 | $178.97 Million | +36.49% |
| 2016 | $131.13 Million | -60.40% |
| 2015 | $331.13 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Iradimed Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.31 Billion USD |
| MoneyControl | $1.31 Billion USD |
| MarketWatch | $1.31 Billion USD |
| marketcap.company | $1.31 Billion USD |
| Reuters | $1.31 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.